SLNO•benzinga•
Soleno Therapeutics' Marketing Authorization Application For Diazoxide Choline Prolonged-Release Tablets In Treating Hyperphagia In Adults And Children With Prader-Willi Syndrome Validated By European Medicines Agency
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on May 22, 2025 by benzinga